Thus, NaV1.7 acts as an amplifier of the receptor potential in nociceptive neurons and plays a critical role in inherited erythromelalgia and paroxysmal extreme pain disorder, as it causes gain-of-function mutations that enable the channel to open with small depolarizations. This evidence concerns the gene SCN9A and paroxysmal extreme pain disorder.